SPECIAL ADVISOR TO THE BOARD OF DIRECTORS AND THE CEO AGREEMENTBoard of Directors and the Ceo Agreement • September 9th, 2022 • Curative Biotechnology Inc • Biological products, (no disgnostic substances) • Delaware
THIS AGREEMENT is made and entered into effective as of SEPTEMBER 27, 2021, (the “Effective Date”), by and between Curative Biotechnology Inc., a Florida corporation (the “Company”) with its principal place of business located at 1825 NW Corporate Blvd #110 Boca Raton, Florida , and Sohn Health Strategies LLC, a New Jersey limited liability company (“Advisor”) with a principal place of business at 5 Hidden Acres Drive, Voorhees, NJ 08043.
